Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Works of Yoonjin Cho being referenced
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
2014
Update on a Phase 2 Study of Idelalisib in Combination with Rituximab in Treatment-Naïve Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yoonjin Cho | 377 | 324 | 5 | 150 | 14 | 473 | |
| Nilima Parry‐Jones | 308 | 309 | 17 | 92 | 19 | 485 | |
| Mads Hansen | 254 | 307 | 1 | 136 | 10 | 491 | |
| Iwona Wlodarska | 227 | 245 | 5 | 91 | 14 | 427 | |
| Evgenii A. Osmanov | 202 | 347 | 4 | 110 | 22 | 484 | |
| Yuh Shan Lee | 372 | 344 | 64 | 17 | 510 | ||
| Lucia Morello | 313 | 307 | 9 | 82 | 15 | 429 | |
| Kamlai Saiya-Cork | 196 | 218 | 8 | 187 | 15 | 473 | |
| Елена Бибикова | 318 | 234 | 15 | 182 | 15 | 515 | |
| Gianluca Schiavoni | 269 | 170 | 14 | 182 | 17 | 431 | |
| Arnau Montraveta | 234 | 180 | 2 | 279 | 17 | 486 |
All Works
Login with ORCID to disown or claim papers
Loading papers...